SEMPER TIGRIS

Serial Number 90350147
Registration 6593757
700

Registration Progress

Application Filed
Nov 30, 2020
Under Examination
Approved for Publication
Oct 5, 2021
Published for Opposition
Oct 5, 2021
Registered
Dec 21, 2021

Trademark Image

SEMPER TIGRIS

Basic Information

Serial Number
90350147
Registration Number
6593757
Filing Date
November 30, 2020
Registration Date
December 21, 2021
Published for Opposition
October 5, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 21, 2021
Registration
Registered
Classes
042

Rights Holder

The Larvol Group, LLC

16
Address
548 Market Street, Suite 44120
San Francisco, CA 94104

Ownership History

The Larvol Group, LLC

Original Applicant
16
San Francisco, CA

The Larvol Group, LLC

Owner at Publication
16
San Francisco, CA

The Larvol Group, LLC

Original Registrant
16
San Francisco, CA

Legal Representation

Attorney
Roy S. Gordet

USPTO Deadlines

Next Deadline
882 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-12-21)
Due Date
December 21, 2027
Grace Period Ends
June 21, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

21 events
Date Code Type Description Documents
Dec 21, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 5, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 5, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 15, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 31, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 24, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 24, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 24, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 24, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 16, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
Aug 16, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Aug 16, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jul 15, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 14, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 14, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 7, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 7, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 7, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 29, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 5, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 3, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Developing and providing an online searchable database in the fields of pharmaceuticals, biotechnology, life sciences and health sciences featuring scientific research; software development in the field of life sciences and health sciences software as a service (SAAS) services featuring software for information processing in connection with the provision of business data analytics services to the life science industries; software as a service (SAAS) services featuring software for information processing in connection with the provision of business data analytics services to the life science industries; software as a service (SAAS) services featuring the monitoring and reporting on the scientific and professional activities of key opinion leaders in the pharmaceutical industry; software as a service (SAAS) services featuring conference planners incorporating spreadsheet software and designed to support the needs of professionals and competitive intelligence teams attending conferences, congresses and similar events in the pharmaceutical and health sciences industries; providing scientific information in the fields of life science, pharmaceuticals and biotechnology to the pharmaceutical and biotechnology industries; providing scientific information relating to the pharmaceutical and biotechnology industries; providing scientific research information on cancer diagnostics and cancer biomarkers; providing reports on new products and product development, all of the foregoing reporting concerning pharmaceuticals and the U.S. and international pharmaceutical industry; data compiling and analyzing for scientific research purposes in the fields of pharmaceuticals, biotechnology, life sciences and health sciences; providing scientific research information in the fields of pharmaceuticals, biotechnology and health sciences
First Use Anywhere: Nov 11, 2020
First Use in Commerce: Nov 11, 2020

Additional Information

Translation
The English translation of "SEMPER TIGRIS" in the mark is "ALWAYS A TIGER".

Classification

International Classes
042